Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Dosage Forms × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

pembrolizumab 257 Nivolumab 150 Carboplatin 145 Cyclophosphamide 127 Paclitaxel 121 Cisplatin 117 Dexamethasone 82 Radiotherapy 82 Ipilimumab 75 Magnetic Resonance Spectroscopy 74 Gemcitabine 73 Doxorubicin 69 Rituximab 68 Specimen Handling 66 Etoposide 64 Biopsy 62 Docetaxel 62 Lenalidomide 61 Prednisone 61 atezolizumab 55 Radiation 54 Bevacizumab 50 Cytarabine 50 Pemetrexed 50 Taxes 49 durvalumab 49 fludarabine 49 Vincristine 48 olaparib 45 Fluorouracil 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05309668 2025-12-18

SPRINKLE

AstraZeneca

Phase 1/2 Active not recruiting

36 enrolled 37 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡